Literature DB >> 4984091

Patient dosimetry in the electron treatment of large superficial lesions.

V Page, A Gardner, C J Karzmark.   

Abstract

Entities:  

Mesh：

Year:  1970        PMID： 4984091     DOI： 10.1148/94.3.635

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  6 in total

Review 1.  The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications.

Authors:  Ercole Mazzeo; Laura Rubino; Michela Buglione; Paolo Antognoni; Stefano Maria Magrini; Francesco Bertoni; Manuela Parmiggiani; Paola Barbieri; Filippo Bertoni
Journal:  Rep Pract Oncol Radiother       Date:  2013-08-13

2.  Rotational subtotal skin electron beam therapy for management of carcinoma en cuirasse.

Authors:  P P Kumar; R R Good; E O Jones
Journal:  J Natl Med Assoc       Date:  1987-07       Impact factor: 1.798

3.  Early experience in using and 18 Me V linear accelerator for mycosis fungoides at Howard University Hospital.

Authors:  P P Kumar; K Henschke; K P Mandal; J R Nibhanupudy; I S Patel
Journal:  J Natl Med Assoc       Date:  1977-04-01       Impact factor: 1.798

4.  In-vivo dosimetric analysis in total skin electron beam therapy.

Authors:  Khaled Elsayad; Christos Moustakis; Manuela Simonsen; Dagmar Bäcker; Uwe Haverkamp; Hans Theodor Eich
Journal:  Phys Imaging Radiat Oncol       Date:  2018-05-19

5.  In vivo dosimetry for testicular and scalp shielding in total skin electron therapy using a radiophotoluminescence glass dosimeter.

Authors:  Hiroyuki Okamoto; Kae Okuma; Hiroki Nakayama; Satoshi Nakamura; Kotaro Iijima; Takahito Chiba; Mihiro Takemori; Kyohei Fujii; Shohei Mikasa; Tetsu Nakaichi; Ako Aikawa; Shouichi Katsuta; Hiroshi Igaki
Journal:  J Radiat Res       Date:  2022-01-20       Impact factor: 2.724

6.  Acute and sub-acute toxicity profile of ultra-hypofractionated low-dose total skin electron beam with two 4 Gy fractions for cutaneous T cell lymphoma.

Authors:  Daniel Rolf; Khaled Elsayad; Hans Theodor Eich
Journal:  J Cancer Res Clin Oncol       Date:  2020-11-21       Impact factor: 4.553
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.